Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for Aurinia Pharmaceuticals Inc. (AUPH)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
6 days ago | Business Wire
a week ago | The Motley Fool
a week ago | Pulse2
a week ago | Zacks Investment Research
a week ago | Business Wire
2 weeks ago | Zacks Investment Research
2 weeks ago | Business Wire
0 months ago | Business Wire
a month ago | Business Wire
About:
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.